GA
TMO icon

Goldstein Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Goldstein Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
555
+20
+4% +$9.6K 0.03% 200
2026
Q1 		$263K Buy
535
+68
+15% +$36.9K 0.03% 172
2025
Q4 		$271K Buy
467
+2
+0.4% +$1.13K 0.03% 162
2025
Q3 		$226K Sell
465
-167
-26% -$77.7K 0.03% 183
2025
Q2 		$256K Buy
632
+76
+14% +$31.8K 0.03% 156
2025
Q1 		$277K Buy
556
+2
+0.4% +$1.08K 0.04% 143
2024
Q4 		$288K Sell
554
-78
-12% -$42.9K 0.04% 140
2024
Q3 		$391K Buy
632
+8
+1% +$4.74K 0.06% 103
2024
Q2 		$345K Buy
624
+84
+16% +$48.1K 0.06% 103
2024
Q1 		$314K Sell
540
-8
-1% -$4.49K 0.05% 109
2023
Q4 		$291K Sell
548
-88
-14% -$42.6K 0.05% 141
2023
Q3 		$322K Sell
636
-61
-9% -$32.5K 0.07% 99
2023
Q2 		$364K Sell
697
-24
-3% -$13K 0.08% 94
2023
Q1 		$416K Sell
721
-9
-1% -$5.07K 0.09% 83
2022
Q4 		$402K Buy
+730
New +$387K 0.1% 84

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goldstein Advisors's TMO Position: Q2 2026 in Review

Goldstein Advisors increased its Thermo Fisher Scientific (TMO) stake by 3.7% in Q2 2026, buying an estimated $9.6K and bringing the position to 555 shares worth $278K. The position accounts for 0.03% of the portfolio, ranked #200.

Goldstein Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $416K in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Goldstein Advisors held 555 shares of Thermo Fisher Scientific worth $278K as of Q2 2026.
  • Goldstein Advisors bought 20 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.6K.
  • Thermo Fisher Scientific made up 0.03% of Goldstein Advisors's portfolio in Q2 2026, its #200 holding.
  • Goldstein Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Goldstein Advisors's Thermo Fisher Scientific position peaked at $416K in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.